These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 7574768

  • 1. [Clinical effects and immunological analysis of intraabdominal and intrapleural injection of lentinan for malignant ascites and pleural effusion of gastric carcinoma].
    Hazama S, Oka M, Yoshino S, Iizuka N, Wadamori K, Yamamoto K, Hirazawa K, Wang F, Ogura Y, Masaki Y.
    Gan To Kagaku Ryoho; 1995 Sep; 22(11):1595-7. PubMed ID: 7574768
    [Abstract] [Full Text] [Related]

  • 2. [Effect of intrapleural and/or intraperitoneal lentinan therapy in carcinomatous pleuritis and peritonitis].
    Yoshino S, Oka M, Hazama S, Suzuki T.
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1588-91. PubMed ID: 2389953
    [Abstract] [Full Text] [Related]

  • 3. Immunological analysis and clinical effects of intraabdominal and intrapleural injection of lentinan for malignant ascites and pleural effusion.
    Oka M, Yoshino S, Hazama S, Shimoda K, Suzuki T.
    Biotherapy; 1992 Aug; 5(2):107-12. PubMed ID: 1524950
    [Abstract] [Full Text] [Related]

  • 4. A new approach to the treatment of malignant effusion.
    Li DJ, Wang YR, Tan XY, Wang HZ, Yao XD, Ba DN.
    Chin Med J (Engl); 1990 Dec; 103(12):998-1002. PubMed ID: 2127253
    [Abstract] [Full Text] [Related]

  • 5. Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parameters.
    Stathopoulos GP, Baxevanis CN, Papadopoulos NG, Zarkadis IK, Papacostas P, Michailakis E, Tsiatas ML, Papamichail M.
    Anticancer Res; 1996 Dec; 16(6B):3855-60. PubMed ID: 9042270
    [Abstract] [Full Text] [Related]

  • 6. Soluble HLA class I molecules in malignant pleural and peritoneal effusions and its possible role on NK and LAK cytotoxicity.
    Amirghofran Z, Sheikhi AK, Kumar PV, Saberi Firouzi M.
    J Cancer Res Clin Oncol; 2002 Aug; 128(8):443-8. PubMed ID: 12200601
    [Abstract] [Full Text] [Related]

  • 7. Without prior stimulation, tumor-associated lymphocytes from malignant effusions lyse autologous tumor cells in the presence of bispecific antibody HEA125xOKT3.
    Strauss G, Gückel B, Wallwiener D, Moldenhauer G.
    Clin Cancer Res; 1999 Jan; 5(1):171-80. PubMed ID: 9918216
    [Abstract] [Full Text] [Related]

  • 8. [The cytotoxicity of malignant pleural effusion lymphocytes and LAK cells against autologous tumor cells].
    Guo Y, Xing Z.
    Zhonghua Jie He He Hu Xi Za Zhi; 1995 Apr; 18(2):80-2, 127. PubMed ID: 7553955
    [Abstract] [Full Text] [Related]

  • 9. [Effectiveness of treatment with transfer of autologous or allogenic LAK cells combined with rIL-2 in 121 patients with malignant pleural effusion].
    Liu X.
    Zhonghua Zhong Liu Za Zhi; 1993 May; 15(3):205-8. PubMed ID: 8261867
    [Abstract] [Full Text] [Related]

  • 10. [In vitro induction of cytotoxic activity against carcinomatous pleural or peritoneal lymphoid cells cultivated with cytokines, and an immunological phenotypic analysis of the effector cells].
    Ebihara T, Koyama S.
    Gan No Rinsho; 1990 Apr; 36(5):604-10. PubMed ID: 2325266
    [Abstract] [Full Text] [Related]

  • 11. A study of the cytotoxicity of malignant pleural effusion lymphocytes and LAK cells against autologous tumor cells.
    Guo YS, Xing ZL.
    Chin Med J (Engl); 1994 Dec; 107(12):903-5. PubMed ID: 7882727
    [Abstract] [Full Text] [Related]

  • 12. [Induction by local injections of IL-2 of antitumor effector cells and secondary production of cytokines in malignant pleural effusion].
    Sone S, Yanagawa H, Nii A, Ozaki T, Ogura T.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Aug; 30(8):1434-40. PubMed ID: 1434216
    [Abstract] [Full Text] [Related]

  • 13. [Phase III clinical trial of elemenum emulsion in the management of malignant pleural and peritoneal effusions].
    Wang J, Zhang H, Sun Y.
    Zhonghua Zhong Liu Za Zhi; 1996 Nov; 18(6):464-7. PubMed ID: 9387305
    [Abstract] [Full Text] [Related]

  • 14. Profile of T-cell receptor V beta gene usage of cytotoxic T cells induced by intrapleural administration of a streptococcal preparation, OK432, in malignant effusions.
    Miyahara E, Yamaguchi Y, Hihara J, Noma K, Toge T.
    J Exp Ther Oncol; 1996 Jul; 1(4):242-50. PubMed ID: 9414411
    [Abstract] [Full Text] [Related]

  • 15. Combined immunotherapy with intracavital injection of activated lymphocytes, monocyte-derived dendritic cells and low-dose OK-432 in patients with malignant effusion.
    Morisaki T, Matsumoto K, Kuroki H, Kubo M, Baba E, Onishi H, Tasaki A, Nakamura M, Inaba S, Katano M.
    Anticancer Res; 2003 Jul; 23(6a):4459-65. PubMed ID: 14666734
    [Abstract] [Full Text] [Related]

  • 16. [Scanning electron microscopic observation of mouse ascitic carcinoma cells after intraperitoneal administration of lentinan].
    Kurokawa T, Tamakuma S.
    Nihon Gan Chiryo Gakkai Shi; 1990 Dec 20; 25(12):2822-7. PubMed ID: 2074392
    [Abstract] [Full Text] [Related]

  • 17. [Clinical evaluation of the combination treatment of intrapleural or intraperitoneal administration of lentinan and OK-432 for malignant effusion].
    Yoshino S, Yoshida S, Maeda N, Maeda Y, Maeda K, Hazama S, Oka M.
    Gan To Kagaku Ryoho; 2010 Nov 20; 37(12):2798-800. PubMed ID: 21224717
    [Abstract] [Full Text] [Related]

  • 18. The characterization of peritoneal and pleural exudate cells from malignant effusions.
    Oka M, Yoshino S, Hazama S, Shimoda K, Suzuki T.
    Surg Today; 1993 Nov 20; 23(6):500-3. PubMed ID: 8102920
    [Abstract] [Full Text] [Related]

  • 19. Generation of lymphokine-activated killer (LAK) cell activity from malignant peritoneal effusions.
    Chao TY, Hwang WS, Yeh MY.
    Proc Natl Sci Counc Repub China B; 1995 Apr 20; 19(2):92-8. PubMed ID: 7624448
    [Abstract] [Full Text] [Related]

  • 20. [Intrapleural administration of LAK cells combined with rIL2 in the treatment of advanced lung cancer with malignant pleural effusion].
    Mao G, Gao Z, Wang Q.
    Zhonghua Jie He He Hu Xi Za Zhi; 1995 Apr 20; 18(2):83-4, 127. PubMed ID: 7553956
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.